Global Picrotoxin market size was valued at USD 8.2 million in 2024 and is projected to grow from USD 8.9 million in 2025 to USD 13.6 million by 2032, exhibiting a CAGR of 6.1% during the forecast period.
Picrotoxin is a potent GABA receptor antagonist derived from Anamirta cocculus plants, primarily used in neurological research and pharmaceutical applications. This toxic compound serves as a crucial tool for studying inhibitory neurotransmission mechanisms.
The specialized nature of the picrotoxin market reflects its niche yet essential role in neuroscience research and drug development sectors. Market growth is fueled by increasing CNS disorder research, expanding pharmaceutical R&D budgets, and the growing prevalence of neurological conditions requiring novel therapeutic approaches.
Read Full Report Here: Picrotoxin Market – View in Detailed Research Report
Segmentation by Suppliers
The picrotoxin supply chain features several key manufacturers and distributors specializing in high-purity neuroscience research compounds:
1. Merck KGaA
As a global life science leader, Merck offers research-grade picrotoxin through its MilliporeSigma portfolio, serving academic and pharmaceutical clients worldwide.
-
Market Insight: Merck maintains approximately 35% market share due to its extensive distribution network and quality assurance protocols.
-
Trend: The company has recently expanded neurological compound production capacity to meet growing demand from North American and European research institutions.
2. Cayman Chemical
This US-based specialty chemical manufacturer provides high-purity picrotoxin formulations for preclinical research applications.
-
Market Insight: Cayman holds about 25% market share, with particular strength in custom purity formulations for electrophysiology studies.
-
Trend: The company is investing in novel GABA-related research compounds to complement its picrotoxin product line.
3. Biosynth Carbosynth
A Swiss specialty chemicals firm offering picrotoxin and related neuroscience research compounds with extensive documentation for regulatory compliance.
-
Market Insight: Commands 20% market share with strong presence in European academic research markets.
-
Trend: Expanding API-grade production capabilities to serve pharmaceutical customers developing CNS drugs.
4. Alomone Labs
Specialist provider of ion channel modulators and neuroscientific research tools, including high-purity picrotoxin formulations.
-
Market Insight: Holds 15% market share with focus on electrophysiology research applications.
-
Trend: Developing specialized formulations for advanced seizure disorder research models.
Download FREE Sample Report:
